Medical Market Report

Global Insulin delivery system Market By Type (Insulin Pen, Insulin Pump, Insulin Syringe, Others) By Distribution Channel (Hospitals, Diabetes Specialty Clinics, Retail Channels), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2020-2027

  • 134352
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Insulin delivery system Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global Insulin delivery system Market is segmented on the basis of Type, Application, and geography.
    The Global Insulin Delivery Systems Market is estimated to reach a value of over US$ 11,417.1 Mn in 2017 at a CAGR of over 7.0% over the forecast period.
    Insulin delivery system Market Scope:

    By product, the market is segmented into Insulin Pen, Insulin Pump, Insulin Syringe, Others. By distribution channel the market is segmented into Hospitals, Diabetes Specialty Clinics, Retail Channels.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Becton, Dickinson and Company, Eli Lilly and Company, Medtronic plc, Sanofi, Hoffmann-La Roche Ltd., Cellnovo Limited, Insulet Corporation, Tandem Diabetes Care Inc, Companion Medical Inc, Copernicus Sp. z o.o.

    Key Market Segments:
    Product:

    Insulin Pen
    Insulin Pump
    Insulin Syringe
    Others

    Distribution channel:

    Hospitals
    Diabetes Specialty Clinics
    Retail Channels

    Key Market Players included in the report:

    Becton, Dickinson and Company
    Eli Lilly and Company
    Medtronic plc
    Sanofi
    Hoffmann-La Roche Ltd.
    Cellnovo Limited
    Insulet Corporation
    Tandem Diabetes Care, Inc.
    Companion Medical, Inc.
    Copernicus Sp. z o.o.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Insulin delivery system Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Insulin delivery system Market, high-growth regions, and market drivers, restraints and also market chances.
    The analysis covers Insulin delivery system Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Insulin delivery system Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Insulin delivery system Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    To know the Insulin delivery system Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Allergy Diagnostics sub-markets, depending on key regions (various vital states).
    To analyze Insulin delivery system Market concerning growth trends, prospects and also their participation in the entire sector.
    To examine and study the Insulin delivery system Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2019 and also prediction to 2027.
    Primary worldwide Insulin delivery system Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

  • Table Of Content 
    1.0 Chapter 1
    

    1.1 Preface
    
1.2 Assumptions
    
1.3 Abbreviations
    

    2.0 Chapter 2
    

    2.1 Report Description
    

    2.1.1 Market Definition and Scope
    
2.1.2 Opportunity Map Analysis2.2 Executive Summary
    

    2.2.1 Market Snapshot, By Product
    
2.2.2 Market Snapshot, By Distribution Channel
    
2.2.3 Market Snapshot, By Region
    
3.0 Chapter 3
    

    3.0.1 Global Insulin Delivery Systems Market Dynamics
    
3.0.2 Drivers
    
3.0.3 Restrains
    
3.0.4 Opportunities
    
3.0.5 Trends
    
3.0.6 DR Impact Analysis
    
3.0.7 PEST Analysis
    
3.0.8 Porter?s Five Forces Analysis
    
3.0.9 Percentage of Deaths Attributed to High Blood Glucose at Ages 20?69 Years
    
3.0.10 High Blood Glucose Age-Standardized Mortality Rates
    
3.0.11 Estimated Prevalence and Number of People with Diabetes (2014)
    
3.0.12 Worldwide Prevalence of Diabetes, 2012?2016
    

    4.0 Chapter 4
    

    4.0.1 Global Insulin Delivery Systems Market Analysis, by Product
    
4.0.2 Overview
    
4.0.3 Segment Trends
    
4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016?2026, (US$ Mn)
    
4.1 Insulin Pen
    

    4.1.1 Overview
    
4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)4.2 Insulin Pump
    

    4.2.1 Overview
    
4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
4.2.3 Insulin Pump Hardware Schematic
    
4.2.4 Activity Model of the Insulin Pump4.3 Insulin Syringe
    

    4.3.1 Overview
    
4.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)4.4 Others
    

    4.4.1 Overview
    
4.4.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
5.0 Chapter 5
    

    5.0.1 Global Insulin Delivery Systems Market Analysis, by Distribution Channel
    
5.0.2 Overview
    
5.0.3 Segment Trends
    
5.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
5.1 Hospitals
    

    5.1.1 Overview
    
5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)5.2 Diabetes Specialty Clinics
    

    5.2.1 Overview
    
5.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)5.3 Retail Channels
    

    5.3.1 Overview
    
5.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
6.0 Chapter 6
    

    6.0.1 Global Insulin Delivery Systems Market Analysis, by Region
    
6.0.2 Market Attractiveness Index
    
6.0.3 Overview
    
6.0.4 Regional Trends
    
6.0.5 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
6.1 North America
    

    6.1.1 Overview
    
6.1.2 Country Trends
    
6.1.3 Market Share and Forecast, and Y-o-Y Growth, 2016?2026, (US$ Mn)
    
6.1.4 US
    

    6.1.4.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.1.5 Canada
    

    6.1.5.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.1.6 US Diabetes Forecasts?2015 to 2030
    
6.1.7 Prevalence of Diabetes in 2017, By Country6.2 Europe
    

    6.2.1 Overview
    
6.2.2 Country Trends
    
6.2.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
    
6.2.4 Germany
    

    6.2.4.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.2.5 France
    

    6.2.5.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.2.6 UK
    

    6.2.6.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.2.7 Russia
    

    6.2.7.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.2.8 Italy
    

    6.2.8.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.2.9 Prevalence of Diabetes in 2017, By Country6.3 Asia Pacific
    

    6.3.1 Overview
    
6.3.2 Country Trends
    
6.3.3 Market Share and Forecast, and Y-o-Y Growth, 2016?2026, (US$ Mn)
    
6.3.4 China
    

    6.3.4.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.3.5 Japan
    

    6.3.5.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.3.6 South Korea
    

    6.3.6.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.3.7 India
    

    6.3.7.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.3.8 Southeast Asia
    

    6.3.8.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.3.9 Prevalence of Diabetes in 2017, By Country6.4 Latin America
    

    6.4.1 Overview
    
6.4.2 Country Trends
    
6.4.3 Market Share and Forecast, and Y-o-Y Growth, 2016?2026, (US$ Mn)
    
6.4.4 Brazil
    

    6.4.4.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.4.5 Mexico
    

    6.4.5.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.4.6 Rest of Latin America
    

    6.4.6.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.4.7 Prevalence of Diabetes in 2017, By Country6.5 Middle East & Africa
    

    6.5.1 Overview
    
6.5.2 Country Trends
    
6.5.3 Market Share and Forecast, and Y-o-Y Growth, 2016?2026, (US$ Mn)
    
6.5.4 GCC
    

    6.5.4.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.5.5 Israel
    

    6.5.5.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.5.6 South Africa
    

    6.5.6.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.5.7 Rest of Middle East & Africa
    

    6.5.7.1 Market Value and Forecast, 2016?2026, (US$ Mn)6.5.8 Prevalence of Diabetes in 2017, By Country
    
7.0 Chapter 7
    

    7.0.1 Company Profiles
    
7.0.1 Heat Map Analysis
    
7.1 Becton, Dickinson and Company
    

    7.1.1 Company Overview
    
7.1.2 Product Portfolio
    
7.1.3 Financial Overview
    
7.1.4 Key Developments
    
7.1.5 SWOT Analysis7.2 Eli Lilly and Company
    

    7.2.1 Company Overview
    
7.2.2 Product Portfolio
    
7.2.3 Financial Overview
    
7.2.4 Key Developments
    
7.2.5 SWOT Analysis7.3 Medtronic plc
    

    7.3.1 Company Overview
    
7.3.2 Product Portfolio
    
7.3.3 Financial Overview
    
7.3.4 Key Developments
    
7.3.5 SWOT Analysis7.4 Sanofi
    

    7.4.1 Company Overview
    
7.4.2 Product Portfolio
    
7.4.3 Financial Overview
    
7.4.4 Key Developments
    
7.4.5 SWOT Analysis7.5 F. Hoffmann-La Roche Ltd.
    

    7.5.1 Company Overview
    
7.5.2 Product Portfolio
    
7.5.3 Financial Overview
    
7.5.4 Key Developments
    
7.5.5 SWOT Analysis7.6 Cellnovo Limited
    

    7.6.1 Company Overview
    
7.6.2 Product Portfolio
    
7.6.3 Financial Overview
    
7.6.4 Key Developments
    
7.6.5 SWOT Analysis7.7 Insulet Corporation
    

    7.7.1 Company Overview
    
7.7.2 Product Portfolio
    
7.7.3 Financial Overview
    
7.7.4 Key Developments
    
7.7.5 SWOT Analysis7.8 Tandem Diabetes Care, Inc.
    

    7.8.1 Company Overview
    
7.8.2 Product Portfolio
    
7.8.3 Financial Overview
    
7.8.4 Key Developments
    
7.8.5 SWOT Analysis7.9 Companion Medical, Inc.
    

    7.9.1 Company Overview
    
7.9.2 Product Portfolio
    
7.9.3 Financial Overview
    
7.9.4 Key Developments
    
7.9.5 SWOT Analysis7.10 Copernicus Sp. z o.o.
    

    7.10.1 Company Overview
    
7.10.2 Product Portfolio
    
7.10.3 Financial Overview
    
7.10.4 Key Developments
    
7.10.5 SWOT Analysis
    
8.0 Chapter 8
    

    8.1 Research Methodology
    
8.2 About Us
    
8.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.